Option Focus | Moderna’s $979K October 2026 Call Credit Spread Caps Upside, Yet Bulk-Order Flow Still Leans Bullish Amid 99% IV Percentile

Option Witch
6小時前

Moderna closed at $225.00, showing a 14.21% increase, after opening at $199.00 and trading between $197.17 and $225.00 on volume of about 28.91 million shares.

The options tape featured a dominant call credit spread worth $979.10 thousand in net premium, while aggregate large-trade flow leaned bullish despite that income-oriented structure. With implied volatility near the top of its annual range and call volume outpacing puts by a wide margin, Moderna’s options market reflects elevated premium levels alongside a cautiously constructive directional bias.

>>>Start OPTIONS trading & earn up to SGD 200 in rewards!

Options Indicators

Moderna’s implied volatility is 109.99%, and with an IV percentile of 99.20%, current volatility sits at the very high end of its recent range. That points to an elevated volatility regime in which options are priced expensively, with the IV/HV ratio of 1.47 also showing implied volatility running well above historical realized movement. In practical terms, the options market is embedding very rich premium levels, so outright option buyers are paying up for volatility while premium-selling structures may offer better pricing efficiency, assuming risk is tightly managed.

The Call/Put volume ratio is 1.59.

Large Trades

A call spread structure with a net credit of $979.10 thousand was the standout large trade in MRNA, built as a four-leg combination by selling the October 16, 2026 $217.50 calls and buying the October 16, 2026 $227.50 calls. This is best read as a call credit spread, with the short call strike already in the money versus the $225.00 reference stock price, while the long $227.50 call sits out of the money. Because this combination includes both sell calls and buy calls, its size should be measured by the stated net credit of $979.10 thousand, not by gross leg turnover. Strategically, this points to premium collection with a moderately bearish-to-neutral stance, as the trader benefits if upside remains capped below the higher strike, while the purchased $227.50 calls define risk and limit losses on a stronger rally.

Overall, the bulk-order flow still leans bullish. Despite the displayed top trade being a call credit spread that suggests income generation and some willingness to fade or cap near-term upside, the aggregate large-trade positioning is clearly tilted to the upside, indicating that institutional activity was ultimately more constructive than defensive. In short, market sentiment in MRNA appears cautiously bullish: traders are not chasing unlimited upside aggressively, but the broader block flow suggests expectations for underlying support and a favorable directional bias rather than outright bearish conviction.

Strategy Reference

For traders seeking a lower assignment probability, selling out-of-the-money put credit spreads below $200.00 may align with the bullish bulk flow while requiring less margin than naked short puts.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10